SGLT-2 inhibitors and the metabolic fulcrum

Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 8

Abstract

Treatment potential of sodium glucose transporter-2 (SGLT-2) inhibitors in diabetes was first reported more than two decades ago, but their recently testified effect on reduction of major cardiovascular endpoints in outcome trials has led to renewed enthusiasm in them. Their role in the management of type 2 diabetes assumes more significance given that it is known that kidneys are not just innocent bystanders in this chronic disease, but are also involved in its pathogenesis. Pragmatic useof SGLT-2 inhibitors entails classifying patients based on their metabolic state- the so called metabolic fulcrum. When used in carefully selected patients, these drugs not only help in glycemia control, but also have a variety of favourable effects, like reduction of blood pressure and cardiovascular mortality, and improvement in clinical renal endpoints. In this mini review, we briefly describe the rationale of use of SGLT-2 inhibitors, their effects, usage and major side effects.

Authors and Affiliations

Ashish Sehgal

Keywords

Related Articles

Is anaesthesia a poorly recognised medical speciality

Anaesthesiology today is an upcoming multimodality specialty in medical science with its spectrum ranging from perioperative patient care to pain management, critical care and palliative care. We talk of newer drugs, equ...

All adult diabetes is not type 2 diabetes

This reader friendly article describes the various types of diabetes encountered in adults. It lists clinical and glucophenotypic tips which help differentiate latent auto immune diabetes of the young (MODY), and pancrea...

Awareness of Cancer Cervix and its prevention with HPV vaccine in internees, final MBBS students, Nursing staff and paramedical staff in a teaching institute

Aim of the study to collect information about the specific knowledge and awareness of CaCx and its seriousness & benefits of vaccination and screening. Konaseema Institute of Medical Sciences & Research Foundation (KIMS)...

Iodine in pregnancy

Iodine requirements are increased more than 50% during pregnancy. Iodine deficiency during pregnancy can cause maternal and fetal hypothyroidism and impair neurological development of the fetus. The consequences of iodin...

Rhabdomyosarcoma : a rare case of rhabdomyosarcoma of alveolar type of hand in a 18 year old male

Rhabdomyosarcoma(RMS) is a malignant tumor arising from skeletal tissue. It is the most common sarcoma of childhood comprising of 3-4% of childhood malignancies with 2/3rd of cases being reported in children below age of...

Download PDF file
  • EP ID EP614743
  • DOI -
  • Views 158
  • Downloads 0

How To Cite

Ashish Sehgal (2018). SGLT-2 inhibitors and the metabolic fulcrum. Journal of the Indian Medical Association, 116(8), 51-53. https://europub.co.uk/articles/-A-614743